This article does not say why the Gleevec patent was rejected, maybe it was not the purpose of the article. Indian companies did not invest in clinical trials,

This article does not say why the Gleevec patent was rejected, maybe it was not the purpose of the article. Indian companies did not invest in clinical trials, even in the discovery of the molecule. They are just using the disclosures. Even if there is compulsory licencing there should be a cost, about 20 million dollars would be okay based on the average research cost and population of India. I dont believe in compulsory licencing but believe in price control. Let those patent holder companies have exclusive rights but govt should have the right to determine the price based on the purchasing power of the people. The better option of course is govt or the insurance companies negotiate with patent holder. But in India there is no health insurance run by govt that addresses the real price of drugs. Most of the insurance for poor is like a fixed amount like Rs. 30 thousand which does not even cover 10 days in hospital. The price control is supposed to make the cost of healthcare down, but there is no control of the cost of surgical procedures.